Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
synthetic vitamin D analog |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A11CC04
|
| gptkbp:brand |
Hectorol
|
| gptkbp:CASNumber |
54573-75-0
|
| gptkbp:chemicalFormula |
C28H44O2
|
| gptkbp:discoveredBy |
gptkb:Abbott_Laboratories
|
| gptkbp:eliminationHalfLife |
32-37 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
doxercalciferol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
vitamin D receptor agonist
|
| gptkbp:metabolism |
1,25-dihydroxyvitamin D2
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
gptkb:hypercalcemia
hyperphosphatemia |
| gptkbp:usedFor |
gptkb:secondary_hyperparathyroidism
chronic kidney disease |
| gptkbp:bfsParent |
gptkb:calcitriol
|
| gptkbp:bfsLayer |
5
|